Purola Petri K M, Nättinen Janika E, Parkkari Minna M, Ojamo Matti U I, Koskinen Seppo V P, Rissanen Harri A, Sainio Päivi R J, Uusitalo Hannu M T
Department of Ophthalmology, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Finnish Register of Visual Impairment, Finnish Federation of the Visually Impaired, Helsinki, Finland.
Acta Ophthalmol. 2022 Feb;100(1):e221-e232. doi: 10.1111/aos.14883. Epub 2021 May 6.
To evaluate the impact of glaucoma on health-related quality of life (HRQoL) and mental health in the ageing population of Finland.
Altogether 7380 and 5774 Finnish individuals aged 30 years and older with known eye disease status were studied in 2000 and 2011, respectively, in two population-based surveys, including an 11-year follow-up of 4683 participants. Data on HRQoL (EQ-5D-3L, 15D), depression (BDI), psychological distress (GHQ-12) and eye disease diagnoses were obtained from self-reported assessments. Information on glaucoma was complemented with the medication, diagnosis and eye surgery data obtained from the Finnish Health Registries. Distance visual acuity was assessed using the Snellen eye chart test. In logistic regression analyses, data were corrected for age, gender and the most common comorbidities.
Glaucoma patients with verified diagnosis (n = 192 in 2000, n = 202 in 2011) and individuals with self-suspected glaucoma (n = 100 in 2000, n = 41 in 2011) showed a significant decrease in their HRQoL. Glaucoma was also associated with worsened overall mental health based on BDI and GHQ-12 results. Visual impairment associated with glaucoma is the major determinant of the reduced HRQoL and mental health. Neither glaucoma medication nor glaucoma surgery affected these parameters. The impact of glaucoma on HRQoL and mental health diminished between 2000 and 2011 in a cross-sectional setting. The newly diagnosed glaucoma during the 11-year follow-up had a minimal effect on them.
Glaucoma patients show reduced HRQoL and mental health, which is associated with vision loss regardless of the awareness or treatment of the disease. However, this effect seems to be diminishing over time, and the newly diagnosed glaucoma did not show a significant effect on either HRQoL or mental health.
评估青光眼对芬兰老年人群健康相关生活质量(HRQoL)和心理健康的影响。
分别在2000年和2011年对7380名和5774名30岁及以上已知眼病状况的芬兰人进行了两项基于人群的调查研究,其中4683名参与者进行了为期11年的随访。HRQoL(EQ-5D-3L、15D)、抑郁(BDI)、心理困扰(GHQ-12)和眼病诊断数据通过自我报告评估获得。青光眼信息通过从芬兰健康登记处获得的用药、诊断和眼科手术数据进行补充。使用斯内伦视力表测试评估远距离视力。在逻辑回归分析中,对年龄、性别和最常见的合并症数据进行了校正。
确诊青光眼患者(2000年n = 192,2011年n = 202)和自我怀疑青光眼患者(2000年n = 100,2011年n = 41)的HRQoL显著下降。根据BDI和GHQ-12结果,青光眼还与整体心理健康恶化有关。与青光眼相关的视力损害是HRQoL降低和心理健康的主要决定因素。青光眼药物治疗和青光眼手术均未影响这些参数。在横断面研究中,2000年至2011年期间青光眼对HRQoL和心理健康的影响有所减弱。11年随访期间新诊断的青光眼对其影响最小。
青光眼患者的HRQoL和心理健康降低,这与视力丧失有关,无论疾病是否被知晓或治疗。然而,这种影响似乎随着时间的推移而减弱,新诊断的青光眼对HRQoL或心理健康均未显示出显著影响。